The essential nutrient can kill drug-resistant Mycobacterium tuberculosis by producing oxidative radicals that damage DNA.
Advertisement
The Scientist
Most Recent
Experimental cancer therapeutics delivered to tumors via nanoparticles could provide a safer and more effective therapy than conventional chemotherapy.
A court ruling that stops the European Medicines Agency from releasing data from two US companies calls into question the agency’s push for transparency.
A researcher working for a US pharmaceutical company’s Scotland branch is sent to prison for falsifying safety test data on experimental drugs due for clinical trials.
A newly developed drug, modeled after a bacteria-infecting virus, is less likely to become antibiotic resistant.
After a family friend died of pancreatic cancer, high school sophomore Jack Andraka invented a diagnostic strip that could detect the disease in its early stages.
The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.
$700,000 worth of gold dust has been reported missing from a Pfizer medical research lab in Missouri.
The total number of new drugs approved this year ties last year for the highest since 2004, suggesting that the pharmaceutical industry is recovering.
The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
